Latest News and Press Releases

Starts 2018 with Strong Continued Momentum EMERYVILLE, Calif., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced two grants that have...

HEERLEN, the Netherlands and EMERYVILLE, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Royal DSM (AEX:DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc....

EMERYVILLE, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it will hold a special teleconference to provide additional details on its recently announced...

HEERLEN, The Netherlands and EMERYVILLE, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Royal DSM (AEX:DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc....

Q3 2017 GAAP revenues of $24.2 million (excludes $8.3 million for an upfront license agreement with Royal DSM executed in Q3 and fully paid early in Q4 2017) and Non-GAAP Q3 revenues of $32.5 million...

EMERYVILLE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it is rescheduling the release of its financial results for the third quarter ended September...

HAMBURG, Germany and EMERYVILLE, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- H&R USA (H&R), a company of The Hansen & Rosenthal Group, of Hamburg (Germany), and Novvi LLC today announced...

EMERYVILLE, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2017 after market close on Wednesday,...

EMERYVILLE, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that Eduardo Alvarez, an experienced executive who has led...

EMERYVILLE, Calif., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has entered into a product development and production...